Arrivent Biopharma, Inc. · NASDAQ:AVBP
Montanova Capital, LLC reported a 9.90% stake in Arrivent Biopharma, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
Montanova Capital, LLC reported a 9.90% stake in Arrivent Biopharma, Inc., 3,412,788 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 3,412,788
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Suvretta Capital Management, LLC | 9.90% | 3,412,788 |
| Averill Master Fund, Ltd. | 8.70% | 2,969,098 |
| Aaron Cowen | 9.90% | 3,412,788 |
Source
Related
- Arrivent Biopharma, Inc.
- Montanova Capital, LLC
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026